METTL3-mediated ALDH m6A methylation regulates the malignant behavior of BMI1+ HNSCC stem cells
- PMID: 37249063
- DOI: 10.1111/odi.14609
METTL3-mediated ALDH m6A methylation regulates the malignant behavior of BMI1+ HNSCC stem cells
Abstract
Objectives: To reveal the effect and mechanism of methyltransferase-like 3 (METTL3) on cancer stem cells (CSCs) of head and neck squamous cell carcinoma (HNSCC).
Materials and methods: First, we analyzed 14-HNSCC-patients' scRNA-seq dataset and TCGA dataset of HNSCC. Then, Mettl3 knockout or overexpression mice models were studied via tracing and staining technologies. In addition, we took flow cytometry sorting and sphere formation assays to observe tumorigenicity and used cell transfection and western blotting to verify target protein expression levels. Furthermore, methylated RNA immunoprecipitation sequencing (MeRIP-seq) and MeRIP-quantitative real-time PCR (MeRIP-qPCR) were taken to identify the mechanism of Mettl3 regulating Bmi1+ CSCs in HNSCC.
Results: Due to SOX4 transcriptional regulation, METTL3 regulated the malignant behavior of BMI1+ HNSCC stem cells through cell division pathway. The progression and malignancy of HNSCC were decreased after Mettl3 knocked-out, while increased after Mettl3 knocked-in in Bmi1+ CSCs in vivo. Knockdown of Mettl3 inhibited stemness properties of CSCs in vitro. Mechanically, Mettl3 mediated the m6A modification of ALDH1A3 and ALDH7A1 mRNA in Bmi1+ HNSCC CSCs.
Conclusion: Regulated by SOX4, METTL3-mediated ALDH m6A methylation regulates the malignant behavior of BMI1+ HNSCC CSCs through cell division pathway.
Keywords: ALDH; BMI1; CSCs; HNSCC; METTL3; SOX4.
© 2023 Wiley Periodicals LLC.
Similar articles
-
METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.Mol Ther. 2020 Oct 7;28(10):2177-2190. doi: 10.1016/j.ymthe.2020.06.024. Epub 2020 Jun 24. Mol Ther. 2020. PMID: 32621798 Free PMC article.
-
MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.J Pathol. 2011 Mar;223(4):482-95. doi: 10.1002/path.2826. Epub 2011 Jan 5. J Pathol. 2011. PMID: 21294122
-
SOX18 meditates the resistance of Bmi1-expressing cells to cetuximab in HNSCC.Oral Dis. 2024 Apr;30(3):1100-1113. doi: 10.1111/odi.14596. Epub 2023 May 15. Oral Dis. 2024. PMID: 37184032
-
Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.Int J Mol Sci. 2017 Aug 24;18(9):1849. doi: 10.3390/ijms18091849. Int J Mol Sci. 2017. PMID: 28837080 Free PMC article. Review.
-
C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.Oral Oncol. 2014 Jul;50(7):633-9. doi: 10.1016/j.oraloncology.2014.04.004. Epub 2014 May 15. Oral Oncol. 2014. PMID: 24835851 Review.
Cited by
-
A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.Cancers (Basel). 2024 Jun 28;16(13):2397. doi: 10.3390/cancers16132397. Cancers (Basel). 2024. PMID: 39001459 Free PMC article. Review.
-
CSChighE-cadherinlow immunohistochemistry panel predicts poor prognosis in oral squamous cell carcinoma.Sci Rep. 2024 May 8;14(1):10583. doi: 10.1038/s41598-024-55594-5. Sci Rep. 2024. PMID: 38719848 Free PMC article.
-
Regulatory Network of Methyltransferase-Like 3 in Stem Cells: Mechanisms and Medical Implications.Cell Transplant. 2024 Jan-Dec;33:9636897241282792. doi: 10.1177/09636897241282792. Cell Transplant. 2024. PMID: 39466679 Free PMC article. Review.
-
METTL3-Mediated m6A Modification Regulates the Osteogenic Differentiation through LncRNA CUTALP in Periodontal Mesenchymal Stem Cells of Periodontitis Patients.Stem Cells Int. 2024 Jan 19;2024:3361794. doi: 10.1155/2024/3361794. eCollection 2024. Stem Cells Int. 2024. PMID: 38283119 Free PMC article.
References
REFERENCES
-
- Batista, P. J., Molinie, B., Wang, J., Qu, K., Zhang, J., Li, L., Bouley, D. M., Lujan, E., Haddad, B., Daneshvar, K., Carter, A. C., Flynn, R. A., Zhou, C., Lim, K. S., Dedon, P., Wernig, M., Mullen, A. C., Xing, Y., Giallourakis, C. C., & Chang, H. Y. (2014). m6A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell, 15(6), 707–719.
-
- Boumahdi, S., Driessens, G., Lapouge, G., Rorive, S., Nassar, D., Le Mercier, M., Delatte, B., Caauwe, A., Lenglez, S., Nkusi, E., Brohée, S., Salmon, I., Dubois, C., del Marmol, V., Fuks, F., Beck, B., & Blanpain, C. (2014). SOX2 controls tumour initiation and cancer stem‐cell functions in squamous‐cell carcinoma. Nature, 511(7508), 246–250.
-
- Chen, D., Wu, M., Li, Y., Chang, I., Yuan, Q., Ekimyan‐Salvo, M., Deng, P., Yu, B., Yu, Y., Dong, J., Szymanski, J. M., Ramadoss, S., Li, J., & Wang, C. Y. (2017). Targeting BMI1(+) cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma. Cell Stem Cell, 20(5), 621–634.e6.
-
- Cui, Q., Shi, H., Ye, P., Li, L., Qu, Q., Sun, G., Sun, G., Lu, Z., Huang, Y., Yang, C. G., Riggs, A. D., He, C., & Shi, Y. (2017). m6A RNA methylation regulates the self‐renewal and tumorigenesis of glioblastoma stem cells. Cell Reports, 18(11), 2622–2634.
-
- Curtarelli, R. B., Gonçalves, J. M., Dos Santos, L. G. P., Savi, M. G., Nör, J. E., Mezzomo, L. A. M., & Cordeiro, M. M. R. (2018). Expression of cancer stem cell biomarkers in human head and neck carcinomas: A systematic review. Stem Cell Reviews and Reports, 14(6), 769–784.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous